Palladium-103 plaque brachytherapy for retinoblastoma: Long term follow up

American Journal of Ophthalmology Case Reports

Paul T. Finger¹  Abhilasha Maheshwari² 

[1] Corresponding author. The New York Eye Cancer Center, 115 East 61st Street, Suite 5A/B, New York, NY, 10065, USA.;Department of Ocular Tumor, Orbital Disease and Ophthalmic Radiation Therapy, The New York Eye Cancer Center, 115 East 61st Street, New York City, New York, 10065, USA;

关键词: Retinoblastoma;    Palladium-103;    Plaque;    Brachytherapy;    Visual acuity;    Survival;   

DOI  :  

来源: DOAJ

【 摘 要 】

Purpose: Radiation has been used in the treatment of retinoblastoma. Herein, we present the novel use of palladium-103 plaque brachytherapy as primary treatment. Observation: An 8-year-old asymptomatic girl presented was found to have a solitary peripheral retinoblastoma in her right eye. She was treated with primary palladium-103 plaque brachytherapy (47.4 Gray over 5 consecutive days). A secondary, vitreous hemorrhage noted 46 months after irradiation was successfully controlled by laser tumor-demarcation. With 19-years follow up, there has been no clinical scleropathy, or local tumor recurrence. The eye yields 20/20 vision and there has been no systemic metastasis. Conclusion and importance: Palladium-103 plaque brachytherapy successfully controlled retinoblastoma, while preserving the globe, vision, and life.

【 授权许可】

Unknown